A new window into Babies' eyes: can advanced imaging improve care for premature infants?

NCT ID NCT06612541

Recruiting now Diagnosis Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study is testing a new, noninvasive imaging device called HH-SECTR to see inside the eyes of premature infants with retinopathy of prematurity (ROP), a condition that can affect vision. The goal is to see if this technology can provide clearer, more detailed images of the retina than standard exams, helping doctors make better decisions about treatment. The study will include preterm infants born between 24 and 34 weeks of gestation and weighing less than 1500 grams at birth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HH-SECTR optical imaging technology
What this could lead to: If successful, this imaging method could help doctors spot and track retinopathy of prematurity more precisely, potentially leading to better and earlier treatment decisions for premature infants.
What could go wrong: This is an early-stage study with a small number of participants. The new imaging technique may not prove more accurate than standard exams, and it may not be feasible in all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY (ROP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth retinopathy of prematurity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINOPATHY OF PREMATURITY (ROP) ROP EXAMINATION

Contacts and locations

Locations

Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.